Retinitis pigmentosa: open trials in Belgium

4 open trials have a site in Belgium. Registry data; only the trial team decides who can take part.

NCT05589714
Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated With Rare Disease-Causing Genetic Variants
Research · Jaeb Center for Health Research
Ghent University, Ghent
Registry updated 2026-10-29
NCT05878860
A Phase 1/2/3 Study of ATSN-201 Gene Therapy in Subjects with RS1-Associated X linked Retinoschisis
Trial Treatment · Phase 3 · Atsena Therapeutics Inc.
Ghent University Hospital
Registry updated 2026-10-19
NCT07854899
Natural History Study of Advanced RCD
Trial Treatment · SparingVision
Ghent university hospital, Ghent
Registry updated 2026-10-08
NCT07807111
Open-Label Study to Evaluate the Safety, Tolerability, and Efficacy of Gene Therapy (SPVN20) in Subjects With Rod-Cone Dystrophy
Trial Treatment · Phase 1/2 · SparingVision
Ghent university hospital, Ghent
Registry updated 2026-09-08

This page is not medical advice. Talk to your doctor before contacting a trial.

Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated With Rare Disease-Causing Genetic Variants